Arnab China

Dr. Arnab China

Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2017 in Nature
Verified
Journal Article
Open access
PDF file
AAAbul Arif
Abul Arif
FTFulvia Terenzi
Fulvia Terenzi
APAlka A. Potdar
Alka A. Potdar
JJJie Jia
Jie Jia
JSJessica Sacks
Jessica Sacks
PFPaul L. Fox
Paul L. Fox
Glutamyl-prolyl tRNA synthetase (EPRS) is a downstream effector of the mTORC1–S6K1 signalling axis and contributes to adiposity and ageing in mice. Mammalian target of rapamycin complex 1 (mTORC1) and p70 ribosomal protein S6 kinase 1 (S6K1) activate pathways that contribute to adipodicity and ageing. However, known mTORC1–S6K1 targets do not account for observed loss-of-function phenotypes, so there are likely to be additional downstream effectors. Here Paul Fox and colleagues show that glutamyl-prolyl-tRNA synthetase (EPRS) is an effector that contributes to adiposity and ageing. EPRS is phosphorylated by mTORC1–S6K1. Mice with phospho-deficient EPRS knocked in have low body weight, reduced adipose tissue mass, and increased lifespan, similar to S6K1-deficient mice or mice with adipocyte-specific deletion of raptor, a component of the mTORC1 complex. EPRS with a phospho-mimetic mutation rescue the body weight and adipodicity of S6K1-deficient mice, showing that EPRS phosphorylation mediates S6K1-dependent metabolic responses. In adipocytes, EPRS phosphorylation seems to be regulated by insulin. Phospho-EPRS interacts with fatty acid transport protein 1 (FATP1), resulting in FATP1 translocation to the plasma membrane and long-chain fatty acid uptake, which may at least partly explain the metabolic phenotype. Metabolic pathways that contribute to adiposity and ageing are activated by the mammalian target of rapamycin complex 1 (mTORC1) and p70 ribosomal protein S6 kinase 1 (S6K1) axis1,2,3. However, known mTORC1–S6K1 targets do not account for observed loss-of-function phenotypes, suggesting that there are additional downstream effectors of this pathway4,5,6. Here we identify glutamyl-prolyl-tRNA synthetase (EPRS) as an mTORC1–S6K1 target that contributes to adiposity and ageing. Phosphorylation of EPRS at Ser999 by mTORC1–S6K1 induces its release from the aminoacyl tRNA multisynthetase complex, which is required for execution of noncanonical functions of EPRS beyond protein synthesis7,8. To investigate the physiological function of EPRS phosphorylation, we generated Eprs knock-in mice bearing phospho-deficient Ser999-to-Ala (S999A) and phospho-mimetic (S999D) mutations. Homozygous S999A mice exhibited low body weight, reduced adipose tissue mass, and increased lifespan, similar to S6K1-deficient mice9,10,11 and mice with adipocyte-specific deficiency of raptor, an mTORC1 constituent12. Substitution of the EprsS999D allele in S6K1-deficient mice normalized body mass and adiposity, indicating that EPRS phosphorylation mediates S6K1-dependent metabolic responses. In adipocytes, insulin stimulated S6K1-dependent EPRS phosphorylation and release from the multisynthetase complex. Interaction screening revealed that phospho-EPRS binds SLC27A1 (that is, fatty acid transport protein 1, FATP1)13,14,15, inducing its translocation to the plasma membrane and long-chain fatty acid uptake. Thus, EPRS and FATP1 are terminal mTORC1–S6K1 axis effectors that are critical for metabolic phenotypes.

1 June 2006 in Protein Science
Verified
Journal Article
Closed access
PDF file
VJVikas Jain
Vikas Jain
RSRaspudin Saleem‐Batcha
Raspudin Saleem‐Batcha
ACArnab China
Arnab China
DCDipanker Chatterji
Dipanker Chatterji

1 January 2009 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Senthilkumar PalaniappanSenthilkumar Palaniappan
Senthilkumar Palaniappan
MDMurugesan Dinakaran
Murugesan Dinakaran
PYPerumal Yogeeswari
Perumal Yogeeswari
DSDharmarajan Sriram
Dharmarajan Sriram
ACArnab China
Arnab China
VNValakunja Nagaraja
Valakunja Nagaraja

15 March 2008 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
MDMurugesan Dinakaran
Murugesan Dinakaran
Senthilkumar PalaniappanSenthilkumar Palaniappan
Senthilkumar Palaniappan
PYPerumal Yogeeswari
Perumal Yogeeswari
ACArnab China
Arnab China
VNValakunja Nagaraja
Valakunja Nagaraja
DSDharmarajan Sriram
Dharmarajan Sriram

1 February 2008 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
MDMurugesan Dinakaran
Murugesan Dinakaran
Senthilkumar PalaniappanSenthilkumar Palaniappan
Senthilkumar Palaniappan
PYPerumal Yogeeswari
Perumal Yogeeswari
ACArnab China
Arnab China
VNValakunja Nagaraja
Valakunja Nagaraja
DSDharmarajan Sriram
Dharmarajan Sriram

26 October 2007 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
DSDharmarajan Sriram
Dharmarajan Sriram
Senthilkumar PalaniappanSenthilkumar Palaniappan
Senthilkumar Palaniappan
MDMurugesan Dinakaran
Murugesan Dinakaran
PYPerumal Yogeeswari
Perumal Yogeeswari
ACArnab China
Arnab China
VNValakunja Nagaraja
Valakunja Nagaraja